Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pretel MJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ayet E; WELAB, Parc Científic Barcelona, Baldiri Reixac 4-8, Barcelona 08028, Spain., Yeste S; WELAB, Parc Científic Barcelona, Baldiri Reixac 4-8, Barcelona 08028, Spain., Reinoso RF; WELAB, Parc Científic Barcelona, Baldiri Reixac 4-8, Barcelona 08028, Spain., Pretel MJ; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals S.A, Barcelona, Spain., Balada A; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals S.A, Barcelona, Spain., Serafini MT; WELAB, Parc Científic Barcelona, Baldiri Reixac 4-8, Barcelona 08028, Spain.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2021 May; Vol. 51 (5), pp. 501-512. Date of Electronic Publication: 2021 Feb 23.
Autor:
Reinoso RF; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain., Yeste S; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain., Ayet E; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain., Pretel MJ; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain., Balada A; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain., Serafini MT; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals, Barcelona, Spain.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2021 Apr; Vol. 51 (4), pp. 373-386. Date of Electronic Publication: 2021 Jan 20.
Autor:
Yeste S; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D., Reinoso RF; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D., Ayet E; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D., Pretel MJ; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D., Balada A; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D., Serafini MT; Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals R&D.
Publikováno v:
Biological & pharmaceutical bulletin [Biol Pharm Bull] 2020; Vol. 43 (1), pp. 68-76.
Autor:
Díaz JL; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Corbera J; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Martínez D; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Bordas M; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Sicre C; Galchimia , Cebreiro s/n 15823 O Pino A Coruña , Spain., Pascual R; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Pretel MJ; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Marín AP; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Montero A; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Dordal A; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Alvarez I; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000., Almansa C; Drug Discovery and Preclinical Development , Esteve, Baldiri Reixach, 4-8 , 08028 Barcelona , Spain . Email: calmansa@esteve.es ; Tel: +34934466000.
Publikováno v:
MedChemComm [Medchemcomm] 2017 Apr 20; Vol. 8 (6), pp. 1246-1254. Date of Electronic Publication: 2017 Apr 20 (Print Publication: 2017).
Autor:
Serafini MT; Department of Pharmacokinetics and Drug Metabolism, Laboratorios Dr. Esteve, S.A., Barcelona, Spain., Puig S, Pretel MJ, García A, Martínez L
Publikováno v:
Methods and findings in experimental and clinical pharmacology [Methods Find Exp Clin Pharmacol] 1997 Jul-Aug; Vol. 19 (6), pp. 407-15.
Autor:
de la Torre R; Department of Pharmacology and Toxicology, Universitat Autònoma de Barcelona, Spain., Badia R, Gonzàlez G, García M, Pretel MJ, Farré M, Segura J
Publikováno v:
Journal of analytical toxicology [J Anal Toxicol] 1996 May-Jun; Vol. 20 (3), pp. 165-70.